leomorphic adenoma, a slow-growing, benign salivary gland tumor with incidence rates between 2.4 and 4.9 per 100 000 persons per year, is the most common salivary gland tumor. 1,2 The current mainstay of treatment for pleomorphic adenoma is surgical excision. 1 However, parotidectomy is associated with significant risk of complications. The rate of permanent facial nerve injury after parotidectomy, for instance, is up to 26% according to a meta-analysis. 3 Other less serious but still common adverse effects of parotidectomy include risks of Frey syndrome, first bite syndrome, and skin hypo-anesthesia. 4 It is also important to consider the perioperative risk of general anesthesia. Consequently, the risk of complications should be considered when recommending surgery. Some of the reasons for recommending parotidectomy include correction of cosmetic deformity caused by a tumor, diagnosis and treatment of potential missed malignant neoplasms, and prevention of malignant transformation.Pleomorphic adenoma is associated with an estimated 1.5% risk of malignant transformation to carcinoma ex pleomorphic adenoma within the first 5 years of diagnosis if left untreated. 5 This risk may increase to 10% if left untreated for more than 15 years. 5 Although the risk of malignant transformation is low, it is substantial for younger patients owing to their longer life expectancy and justifies surgery. However, many patients who receive a diagnosis of pleomorphic adenoma late in life may never develop malignant transformation, and surgery may be associated with unnecessary risk.To our knowledge, there is no consensus regarding optimal management of pleomorphic adenoma in adults. Furthermore, it is unclear at what age parotidectomy ceases to be beneficial for elderly patients with pleomorphic adenoma. This decision analytical model compared parotidectomy with observation for the management of pleomorphic adenoma in adults 50 years or older. The study was intended to support IMPORTANCE There is no consensus regarding optimal management of pleomorphic adenoma in adults.OBJECTIVES To compare parotidectomy with observation for the management of pleomorphic adenoma in patients 50 years or older by age.DESIGN AND SETTING This decision analytical model was performed from November 21, 2019, to June 15, 2020, using a Markov model. Model variables and ranges were selected based on a literature review. A 1-way sensitivity analysis was performed to evaluate the age threshold at which each algorithm, either upfront elective parotidectomy or observation, would be favored. A Monte Carlo probabilistic sensitivity analysis using variable ranges was then performed 5 times with patients in the model assigned a starting age of 50, 60, 70, 80, and 90 years to assess how age at diagnosis would be associated with the model results.MAIN OUTCOMES AND MEASURES Model outcomes were measured with quality-adjusted life-years (QALYs).
RESULTSIn the study models, the age thresholds at which observation became more beneficial than parotidectomy were 88.5 years f...